Tamoxifen Resistance in Breast Cancer
- 1 January 2001
- journal article
- review article
- Published by Springer Nature in Drugs
- Vol. 61 (12) , 1721-1733
- https://doi.org/10.2165/00003495-200161120-00004
Abstract
Tamoxifen has been used for the systemic treatment of patients with breast cancer for nearly three decades. Treatment success is primarily dependent on the presence of the estrogen receptor (ER) in...Keywords
This publication has 151 references indexed in Scilit:
- Distinct types of diffuse large B-cell lymphoma identified by gene expression profilingNature, 2000
- The Hallmarks of CancerCell, 2000
- ERβ: Identification and characterization of a novel human estrogen receptorFEBS Letters, 1996
- Cloning of a novel receptor expressed in rat prostate and ovary.Proceedings of the National Academy of Sciences, 1996
- The significance ofheregulin in breast cancer tumor progression and drug resistanceBreast Cancer Research and Treatment, 1996
- Identification of the breast cancer susceptibility gene BRCA2Nature, 1995
- Steroid-hormone receptors in nonpalpable and more advanced stages of breast cancer. A contribution to the biology and natural history of carcinoma of the female breastCancer, 1990
- TamoxifenDrugs, 1989
- Effects of anti-estrogens on bone in castrated and intact female ratsBreast Cancer Research and Treatment, 1987
- ON THE TREATMENT OF INOPERABLE CASES OF CARCINOMA OF THE MAMMA: SUGGESTIONS FOR A NEW METHOD OF TREATMENT, WITH ILLUSTRATIVE CASES.1The Lancet, 1896